Market Closed -
Other stock markets
|
After market 04:21:24 pm | |||
8.51 USD | -5.55% | 8.585 | +0.88% |
10:08pm | Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing | MT |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
Financials (USD)
Sales 2024 * | 58.86M | Sales 2025 * | 63.02M | Capitalization | 2.14B |
---|---|---|---|---|---|
Net income 2024 * | -401M | Net income 2025 * | -472M | EV / Sales 2024 * | 30.3 x |
Net cash position 2024 * | 358M | Net cash position 2025 * | 336M | EV / Sales 2025 * | 28.6 x |
P/E ratio 2024 * |
-5.48
x | P/E ratio 2025 * |
-4.95
x | Employees | 500 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.87% |
1 day | -4.72% | ||
1 week | +2.78% | ||
Current month | +2.78% | ||
1 month | -3.19% | ||
3 months | -23.68% | ||
6 months | +12.86% | ||
Current year | -13.69% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 13-11-04 | |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-19 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.51% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 8.51 | -5.55% | 3 861 618 |
24-06-06 | 9.01 | -0.88% | 3,394,252 |
24-06-05 | 9.09 | +8.09% | 4,848,535 |
24-06-04 | 8.41 | -2.10% | 2,975,443 |
24-06-03 | 8.59 | +3.74% | 4,637,922 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.69% | 2.14B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- RXRX Stock